Evidence map›Paper›PMID 19357765›Full record

ArticlePloS one2009

A hypomorphic vasopressin allele prevents anxiety-related behavior.

Mirjam Bunck, Ludwig Czibere, Charlotte Horvath, Cornelia Graf, Elisabeth Frank, Melanie S Kessler, Chris Murgatroyd, Bertram Müller-Myhsok, Mariya Gonik, Peter Weber and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
10.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Is Oxytocin "Nature's Medicine"?Pharmacological reviews · 2020
    Review
  9. Review
  10. Article
  11. Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  12. Oxytocin Stimulates Extracellular Ca2+ Influx Through TRPV2 Channels in Hypothalamic Neurons to Exert Its Anxiolytic Effects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  13. Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide S receptor activity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Mirjam BunckMax Planck Institute of Psychiatry, Munich, Germany.
Ludwig Czibere
Charlotte Horvath
Cornelia Graf
Elisabeth Frank
Melanie S Kessler
Chris Murgatroyd
Bertram Müller-Myhsok
Mariya Gonik
Peter Weber
Benno Pütz
Patrik Muigg
Markus Panhuysen
Nicolas Singewald
Thomas Bettecken
Jan M Deussing
Florian Holsboer
Dietmar Spengler
Rainer Landgraf
Max Planck Institute of Psychiatry · DEUniversität Innsbruck · ATHelmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate neurobiological correlates of trait anxiety, CD1 mice were selectively bred for extremes in anxiety-related behavior, with high (HAB) and low (LAB) anxiety-related behavior mice additionally differing in behavioral tests reflecting depression-like behavior. METHODOLOGY/ PRINCIPAL

findingsIn this study, microarray analysis, in situ hybridization, quantitative real-time PCR and immunohistochemistry revealed decreased expression of the vasopressin gene (Avp) in the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei of adult LAB mice compared to HAB, NAB (normal anxiety-related behavior) and HABxLAB F1 intercross controls, without detecting differences in receptor expression or density. By sequencing the regions 2.5 kbp up- and downstream of the Avp gene locus, we could identify several polymorphic loci, differing between the HAB and LAB lines. In the gene promoter, a deletion of twelve bp Delta(-2180-2191) is particularly likely to contribute to the reduced Avp expression detected in LAB animals under basal conditions. Indeed, allele-specific transcription analysis of F1 animals revealed a hypomorphic LAB-specific Avp allele with a reduced transcription rate by 75% compared to the HAB-specific allele, thus explaining line-specific Avp expression profiles and phenotypic features. Accordingly, intra-PVN Avp mRNA levels were found to correlate with anxiety-related and depression-like behaviors. In addition to this correlative evidence, a significant, though moderate, genotype/phenotype association was demonstrated in 258 male mice of a freely-segregating F2 panel, suggesting a causal contribution of the Avp promoter deletion to anxiety-related behavior. DISCUSSION: Thus, the identification of polymorphisms in the Avp gene promoter explains gene expression differences in association with the observed phenotype, thus further strengthening the concept of the critical involvement of centrally released AVP in trait anxiety.

Indexed as

AllelesAnimalsAnxietyArginine VasopressinBehavior, AnimalDepressionFemaleGene Expression ProfilingHumansMaleMiceMotor ActivityNeuropsychological TestsOligonucleotide Array Sequence AnalysisOxytocinParaventricular Hypothalamic NucleusArginine VasopressinOxytocin

Identifiers

PMID19357765
PMCPMC2663030
OpenAlexW2111778134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.